1. Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture
2. Ridgeback Biotherapeutics and drug innovations ventures at Emory partner to develop clinical stage coronavirus treatment. PR Newswire. Mar 2020. https://www.prnewswire.com/news-releases/ridgeback-biotherapeutics-and-drug-innovations-ventures-at-emory-partner-to-develop-clinical-stage-coronavirus-treatment-301027190.html.
3. Merck and Ridgeback Bio collaborate to advance development of novel antiviral candidate, EIDD-2801. Business Wire. Mar 2022. https://www.businesswire.com/news/home/20200526005229/en.
4. Lagevrio 200 mg hard capsules: summary of product characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13044#gref.
5. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template